TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Tumor necrosis factor receptor-associated factor 3 (TRAF3) is crucial for B cell function.
• TRAF3 deficiency is linked to B cell survival and transformation, observed in B cell malignancies.
• The precise mechanism by which TRAF3 restrains B cell survival remains incompletely understood.

Purpose of the Study:

• To elucidate a novel mechanism by which TRAF3 regulates B cell survival.
• To investigate the role of TRAF3 in the context of B cell cancers.
• To identify potential therapeutic targets for B cell malignancies based on TRAF3 function.

Main Methods:

• Analysis of TRAF3-deficient mouse primary B cells.
• Examination of human malignant B cell lines with varying TRAF3 expression.
• Assessment of Pim2 kinase and c-Myc protein levels and ubiquitination.
• Evaluation of cell death sensitivity to Pim inhibitors (SGI-1776, TP-3654) and c-Myc inhibitors.

Main Results:

• TRAF3 deficiency induced pro-survival Pim2 kinase in B cells, independent of NF-κB2 but dependent on STAT3.
• TRAF3 loss led to increased c-Myc protein levels and reduced c-Myc ubiquitination.
• TRAF3-deficient B cells exhibited resistance to Pim inhibitors, while human B cell lines with low TRAF3 were sensitive.
• Combined inhibition of Pim and c-Myc enhanced cell death in TRAF3-deficient B cells and tumor lines.

Conclusions:

• TRAF3 suppresses a critical B cell survival pathway mediated by Pim2 kinase.
• The TRAF3-Pim2-c-Myc axis represents a potential therapeutic vulnerability in B cell malignancies.
• Targeting this axis could offer a novel strategy for treating B cell cancers.